key takeaways from esmo: immunotherapy for renal cell carcinoma
Published 3 years ago • 9 plays • Length 4:55Download video MP4
Download video MP3
Similar videos
-
4:15
key takeaways from esmo: impact of immunotherapy on quality of life
-
7:50
key takeaways from esmo: updates on immunotherapy for bladder cancer
-
5:02
key takeaways from esmo: gastroesophageal cancer
-
4:01
practical issues in immunotherapy for rcc: an update from esmo 2017
-
4:37
key takeaways from esmo: cardiotoxicity in cancer patients
-
11:18
key takeaways from esmo: updates on small-cell lung cancer
-
2:31
key takeaways from esmo: novel frontline therapies for advanced bladder cancer
-
7:14
key takeaways from esmo: covid-19 and cancer care
-
25:09
kidney cancer highlights from esmo 2022
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
0:59
updates in kidney cancer at esmo 2022
-
4:34
key takeaways from esmo: colorectal cancer
-
3:25
esmo 2018: pt2977 for vhl-associated renal cell carcinoma
-
3:58
key takeaways from esmo: enhancing prognostication for glioblastoma
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
8:04
key takeaways from esmo: cdk4/6 inhibitors for metastatic hr /her2- breast cancer
-
7:28
key takeaways from esmo: updates on ovarian cancer
-
39:34
immunotherapy in renal cell carcinoma